HomeAI · summaries
Storia in 3 fonti
Bristol fusion startup raises £23M to produce cancer-fighting isotopes while the rest of the industry is still 20 years away — TFN
Bristol startup Astral Systems has raised £23M in Series A funding to scale fusion reactors that produce medical isotopes for cancer diagnosis and treatment.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thenextweb.com
Astral Systems £23M raise targets cancer isotopes
The Astral Systems £23M raise will scale medical isotopes for cancer scans, from a rare fusion firm already running reactors and earning revenue.
- ·
techfundingnews.com
Bristol fusion startup raises £23M to produce cancer-fighting isotopes while the rest of the industry is still 20 years away — TFN
Bristol startup Astral Systems has raised £23M in Series A funding to scale fusion reactors that produce medical isotopes for cancer diagnosis and treatment.
- ·
tech.eu
Astral Systems raises £23M to tackle the global shortages of medical radioisotopes
Astral Fusion is developing fusion technologies for life-saving radioisotopes, clean energy, and future space exploration.